Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (471-480 of 661) with videos related to

Pageof 67
Sort By:
Quantitative Imaging in Medicine and Surgery|October 13, 2025
Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysisLixiao Liu, Luyao Pan, Chengyang Zou, et al.
International Journal of Pharmaceutics|July 17, 2023
An inflammation-responsive double-layer microneedle patch for recurrent atopic dermatitis therapyLiwan Song, Junjie Chi, Zhenglin Li, et al.
Scientific Reports|August 18, 2017
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR statusHong Jian, Wei Li, Zhiyong Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 30, 2014
Final overall survival results from a phase III, randomized, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804)Hongyun Zhao, Yun Fan, Shenglin Ma, et al.
Future Oncology (London, England)|October 29, 2024
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancerIsamu Okamoto, Shoichi Kuyama, Nicolas Girard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2018
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung CancerShun Lu, Jianhua Chang, Xiaoqing Liu, et al.
Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancerJair Bar, Mona H Cai, Yookyung Christy Choi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE studyYi-Long Wu, Caicun Zhou, Shun Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patientsLiu Yang, Xiaowei Yan, Jie Chen, et al.
Frontiers in Cell and Developmental Biology|October 25, 2023
Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral headJia-Qing Tian, Teng-Fei Wei, Yu-Rou Wei, et al.
Pageof 67

Showing results (471-480 of 661) with videos related to

Sort By:
Pageof 67
Quantitative Imaging in Medicine and Surgery|October 13, 2025
Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysisLixiao Liu, Luyao Pan, Chengyang Zou, et al.
International Journal of Pharmaceutics|July 17, 2023
An inflammation-responsive double-layer microneedle patch for recurrent atopic dermatitis therapyLiwan Song, Junjie Chi, Zhenglin Li, et al.
Scientific Reports|August 18, 2017
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR statusHong Jian, Wei Li, Zhiyong Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 30, 2014
Final overall survival results from a phase III, randomized, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804)Hongyun Zhao, Yun Fan, Shenglin Ma, et al.
Future Oncology (London, England)|October 29, 2024
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancerIsamu Okamoto, Shoichi Kuyama, Nicolas Girard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2018
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung CancerShun Lu, Jianhua Chang, Xiaoqing Liu, et al.
Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancerJair Bar, Mona H Cai, Yookyung Christy Choi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE studyYi-Long Wu, Caicun Zhou, Shun Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patientsLiu Yang, Xiaowei Yan, Jie Chen, et al.
Frontiers in Cell and Developmental Biology|October 25, 2023
Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral headJia-Qing Tian, Teng-Fei Wei, Yu-Rou Wei, et al.
Pageof 67